Dr. Jie Zhou's practice focuses on patent prosecution and counseling for clients in the areas of biotechnology, pharmaceuticals, and Cleantech. She has significant experience developing worldwide patent portfolios for companies of all sizes, from start-ups to multinational corporations. She also advises clients on IP management and strategic portfolio planning.
Dr. Zhou assists clients in designing patent strategies in anticipation of financings, collaborations, strategic partnering, and mergers and acquisitions. This includes advising clients in patent licensing, IP landscape reviews, and strategies for reexaminations and oppositions. She also prepares opinions (patentability, freedom-to-operate, and invalidity) and due diligence reviews for business transactions.
Dr. Zhou has significant experience in developing patent portfolios for companies in the antibody therapeutics field, and has extensive knowledge in IP technologies related to antibody engineering. She represents Genentech, AbGenomics, and KaloBios Pharmaceuticals in the antibody therapeutics area.
She represented Rinat Neuroscience on IP due diligence with potential pharmaceutical partners and IP due diligence on the acquisition by Pfizer. She worked with and advised the client on developing patent portfolios for their lead products for chronic pain treatment, and for Alzheimer's disease.
She also has significant experience and knowledge in IP related to gene therapy and counsels clients Targeted Genetics and Amsterdam Molecular Therapeutics in this area.
In the Cleantech industry, she counsels clients in developing IP strategies that support their long-term business objectives. She currently provides IP strategy counseling to NanoTune Technologies, a venture-backed company working on advanced energy storage technology.